New medicines reach patients every month. Here's what they treat, how they work, and what to watch, click any card for the full bite.
FDA ApprovedNew medicines reach patients every month. Here's what they treat, how they work, and what to watch, click any card for the full bite.The U.S. Food and Drug Administration granted accelerated approval on October 19, 2026, to dostarlimab-gxly (Jemperli) as a standalone treatment for adults with previously untreated stage II or […]
Read the Full Bite →
FDA ApprovedFDA approved the Autus Size-Adjustable Valve, the first heart valve designed to be expanded after implantation as a child grows, potentially reducing repeat open-heart surgeries.
Read the Full Bite →
FDA ApprovedIberdomide is the first FDA-approved CELMoD for multiple myeloma. Here is how it redirects cereblon and the proteasome, what the Phase 3 trial found, and what remains unknown.
Read the Full Bite →
FDA ApprovedImaavy is the first FDA-approved treatment specifically for warm autoimmune hemolytic anemia.
Read the Full Bite →
FDA ApprovedAn engineered HSV-1 plus nivolumab won accelerated approval after PD-1 failure, despite major trial-design concerns.
Read the Full Bite →
FDA ApprovedFDA approved Inluriyo plus Verzenio for ESR1-mutated advanced breast cancer after prior endocrine therapy.
Read the Full Bite →
FDA ApprovedFayuvi is the first FDA-approved treatment for Sanfilippo syndrome type A, using a one-time AAV9 gene therapy to restore SGSH enzyme activity.
Read the Full Bite →
FDA ApprovedFDA authorized Abbott’s Libre Duo 10 Day, the first wearable to continuously monitor both glucose and ketones for people aged 2 years and older with diabetes.
Read the Full Bite →
FDA ApprovedFDA approved Lisraya (brepocitinib) 30 mg once daily for adults with dermatomyositis after the phase 3 VALOR trial showed significant improvement across muscle, skin, and functional outcomes.
Read the Full Bite →
FDA ApprovedRusfertide reduced phlebotomy burden and improved hematocrit control in the 293-patient phase 3 VERIFY trial, leading to FDA approval for adults with polycythemia vera.
Read the Full Bite →
FDA ApprovedZilganersen is the first FDA-approved treatment for Alexander disease, after a pivotal randomized study showed better preservation of gait speed at 61 weeks.
Read the Full Bite →
FDA ApprovedCamizestrant plus a CDK4/6 inhibitor extended median progression-free survival from 9.2 to 16.0 months after an ESR1 resistance mutation emerged before imaging progression.
Read the Full Bite →
FDA ApprovedDaraxonrasib nearly doubled median overall survival versus chemotherapy in a phase 3 trial of previously treated metastatic pancreatic cancer.
Read the Full Bite →
FDA ApprovedApproved for adults with narcolepsy type 1, Orzeyful restores orexin signaling to target the underlying biology of the disorder.
Read the Full Bite →
FDA ApprovedObstructive sleep apnea with obesity
Read the Full Bite →
FDA ApprovedRelapsed/refractory AML with NPM1 mutation
Read the Full Bite →
FDA ApprovedEarly symptomatic Alzheimer’s disease
Read the Full Bite →
FDA ApprovedPulmonary arterial hypertension (PAH)
Read the Full Bite →
FDA ApprovedMASH (fatty liver disease with scarring)
Read the Full Bite →
FDA ApprovedRSV prevention in infants
Read the Full Bite →
FDA Approved